Web-based IVF teaching for Education

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Education
Web-based IVF teaching - Other
Eligibility
18+
Female
What conditions do you have?
Select

Study Summary

This trial is testing whether an IVF web-based teaching tool is better than a didactic lecture in teaching patients, reducing stress, and increasing satisfaction.

Treatment Effectiveness

Study Objectives

1 Primary · 2 Secondary · Reporting Duration: Assessed prior to consenting to IVF treatment and after teaching intervention (within 6-8 weeks)

Week 6
To assess satisfaction in IVF patients after completing either a web-based teaching module or traditional teaching session
Week 8
To assess knowledge in IVF patients after completing either a web-based teaching module or traditional teaching session
To assess stress levels in IVF patients after completing either a web-based teaching module or traditional teaching session

Trial Safety

Trial Design

2 Treatment Groups

Control group
1 of 2
Web-based Teaching Group
1 of 2

Active Control

Experimental Treatment

40 Total Participants · 2 Treatment Groups

Primary Treatment: Web-based IVF teaching · No Placebo Group · N/A

Web-based Teaching GroupExperimental Group · 4 Interventions: Web-based IVF teaching, Knowledge Questionnaire, Perceived Stress Scale, Satisfaction questionnaire · Intervention Types: Other, Other, Other, Other
Control groupActiveComparator Group · 4 Interventions: Knowledge Questionnaire, Perceived Stress Scale, Didactic lecture, Satisfaction questionnaire · Intervention Types: Other, Other, Other, Other

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: assessed prior to consenting to ivf treatment and after teaching intervention (within 6-8 weeks)

Who is running the clinical trial?

Ottawa Fertility CentreLead Sponsor
3 Previous Clinical Trials
268 Total Patients Enrolled
Schering-PloughIndustry Sponsor
162 Previous Clinical Trials
41,480 Total Patients Enrolled
Jason K Min, MDStudy DirectorOttawa Fertility Centre, University of Ottawa
Tannys DR Vause, MDPrincipal InvestigatorOttawa Fertility Centre, University of Ottawa
Mark Evans, MBAStudy DirectorOttawa Fertiilty Centre

Eligibility Criteria

Age 18+ · Female Participants · 5 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You have access to the Internet at home or work.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 10th, 2021

Last Reviewed: November 2nd, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.

Who else is applying?

What state do they live in?
Texas33.3%
North Carolina33.3%
Alabama33.3%
How old are they?
18 - 65100.0%
What site did they apply to?
Ottawa Fertility Centre100.0%
What portion of applicants met pre-screening criteria?
Met criteria66.7%
Did not meet criteria33.3%

How responsive is this trial?

Typically responds via
Email100.0%
References